ANDA 204210, held by Chartwell Molecular. Potassium Chloride.
As of Nov 15, 2026, ANDA 204210 (Potassium Chloride), held by Chartwell Molecular, was first approved by FDA on Mar 28, 2016, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 28, 2016 | Original application | Approved | None posted |
| Potassium Chloride8MEQ · capsule, extended release;oral | Potassium Chloride | Discontinued |
| Potassium Chloride10MEQ · capsule, extended release;oral | Potassium Chloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
